Understanding and Enhancing Health-Related Social Needs (HRSN) Screening Among Community Oncology Practices
- Conditions
- Cancer
- Interventions
- Other: Non-Interventional
- Registration Number
- NCT06412029
- Lead Sponsor
- Wake Forest University Health Sciences
- Brief Summary
This study evaluates health related social needs screening processes in community oncology clinics.
- Detailed Description
The primary objective of this study is to assess current processes around health related social needs (HRSN) screening among NCORP clinics and categorize clinics based on their implementation of HRSN screening. The primary endpoint will be a detailed understanding of current processes, with attention to variability by key clinic characteristics.
There are 3 parts of the study in which participants can participate in one or all parts (3 total).
Part 1: Participants attend training, complete clinic assessments and observations and may complete an interview on study.
Part 2: Identified clinic staff will be interviewed to discuss factors that influence HRSN screening at their clinic and help develop generalized guidance.
Part 3: Participants attend a co-design workshop and complete surveys on study feasibility.
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 144
Part 1
NCORP PRACTICES:
- Must be an affiliate or sub-affiliate of an NCORP Community or Minority Underserved Community site
- Must provide outpatient oncology care
- Must be a NCORP practice (defined as one or more NCORP affiliates/sub-affiliates, that have a common administrative structure and share providers and/or patients)
- Must have identified two or more Practice Staff that are available and willing to participate on the Practice Interest Form
- Must have identified at least 1-3 outpatient oncology clinics willing to participate on the Practice Interest Form
CLINICS:
- 1-3 clinics within the practice should be selected
- Clinics may or may not be located in different physical locations
- The investigators will encourage NCORP practices to select clinics within a practice that differ in current or potential implementation of health related social needs (HRSN) screening (e.g., different clinic workflow or staff, different screening triggers, different tools), so that heterogeneity within NCORP practices can be captured
- Clinics must be willing to allow Practice Staff participants to observe the clinical operations in-person
PRACTICE STAFF:
- Must be willing and able to take time to observe in person and document 1-3 selected clinics within the practice (approximately 2-3 hours per clinic)
- Must be staff at the selected and enrolled practice. Suggestions of appropriate staff are cancer care delivery research (CCDR) Lead, research nurse, clinical research coordinator or NCORP Administrators. Staff members with primary clinical roles may also be appropriate, if available
- Must be willing and able to participate in two 1.5 hour virtual training sessions
- Must be willing to interview Clinic Key Informants (approximately 30 minutes per interview; in-person or remotely over the internet or by phone)
- If the clinic is chosen for Part 2, must be willing to schedule an interview between Clinic Key Informant and Wake Forest health HRSN Study Team or designee
- If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- Must be willing to be recorded when participating in interviews and the workshop.
CLINIC KEY INFORMANT:
- Must be willing to participate in Part 1 Operational Assessment, which involves a semi-structured interview (approximately 30 minutes; in-person or remotely over the internet or by phone) and a brief Non-patient Demographics Survey (approximately 5 minutes)
- If the clinic is chosen for Part 2, must be willing to participate in an additional 45 minute interview (remotely over the internet or by phone)
- If the clinic is chosen for Part 3, must be willing to participate in a three hour or two 1.5 hour in-person (if possible) workshop(s). If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
Part 3
STAFF WORKSHOP PARTICIPANT:
- Must be a clinic stakeholder (e.g., providers, practice managers, etc.) of the selected clinic
- Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- Must be willing to be recorded when participating in interviews and the workshop.
PATIENT WORKSHOP PARTICIPANT:
- Must be a prospective clinic stakeholder (e.g., patient representative) of the selected clinic
- Must be willing and able to participate in a three hour or two 1.5 hour in-person (if possible) recorded workshop. If the clinic schedules an in-person workshop, there will be no hybrid or separate virtual option for those that cannot attend
- Must have received cancer treatment at the selected clinic within the last five years
- Must be willing to be recorded when participating in the workshop.
Part 1
PRACTICE STAFF:
** Unable to understand, read and communicate in English, as the trainings and observations will be documented in English
Part 3
STAFF WORKSHOP PARTICIPANT:
** Unable to understand, read and communicate in English, as the workshop will be conducted in English
PATIENT WORKSHOP PARTICIPANT:
** Unable to understand, read and communicate in English, as the workshop will be conducted in English
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Part 1 Non-Interventional Part 1: Participants attend training, complete clinic assessments and observations and may complete an interview on study. Part 2 Non-Interventional Part 2: Identified clinic staff will be interviewed to discuss factors that influence health related social needs (HRSN) screening at their clinic and help develop generalized guidance. Part 3 Non-Interventional Part 3: Participants attend a co-design workshop and complete surveys on study feasibility.
- Primary Outcome Measures
Name Time Method HRSN screening reach (Part 1) From study enrollment to approximately 4 and 16 weeks post initial study training Determining the perception of the proportion of patients at clinics who are screened for health related social needs (HRSN).
Barriers and facilitators influencing HRSN screening implementation From study enrollment to time completion of key informant interviews, approximately within 6 months Synthesize themes to create a list of barriers and facilitators influencing HRSN screening implementation within high-implementation clinics, moderate-implementation clinics, and low-implementation clinics.
Generation of a tailored implementation plan for each participating clinic Between time of clinic selection and co-design workshop completion, to be no more than 6 months Generation (defined for each clinic as completed or not completed) of a tailored implementation plan for each participating clinic in Part 3 that includes (1) adaptations to current HRSN screening and follow-up processes, and (2) potential implementation strategies to enhance HRSN screening implementation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (36)
FHP Health Center-Guam
🇬🇺Tamuning, Guam
Genesee Hematology Oncology PC
🇺🇸Flint, Michigan, United States
Helen F Graham Cancer Center
🇺🇸Newark, Delaware, United States
Carle at The Riverfront
🇺🇸Danville, Illinois, United States
Carle Physician Group-Effingham
🇺🇸Effingham, Illinois, United States
Carle Physician Group-Mattoon/Charleston
🇺🇸Mattoon, Illinois, United States
Carle Cancer Institute Normal
🇺🇸Normal, Illinois, United States
Illinois CancerCare-Peoria
🇺🇸Peoria, Illinois, United States
Carle Cancer Center
🇺🇸Urbana, Illinois, United States
Mission Cancer and Blood - Ankeny
🇺🇸Ankeny, Iowa, United States
Iowa Methodist Medical Center
🇺🇸Des Moines, Iowa, United States
Mission Cancer and Blood - Des Moines
🇺🇸Des Moines, Iowa, United States
University Medical Center New Orleans
🇺🇸New Orleans, Louisiana, United States
MaineHealth Cancer Care - Brunswick
🇺🇸Brunswick, Maine, United States
Penobscot Bay Medical Center
🇺🇸Rockport, Maine, United States
Christiana Care - Union Hospital
🇺🇸Elkton, Maryland, United States
Cancer Hematology Centers - Flint
🇺🇸Flint, Michigan, United States
Genesys Hurley Cancer Institute
🇺🇸Flint, Michigan, United States
Essentia Health Saint Joseph's Medical Center
🇺🇸Brainerd, Minnesota, United States
Essentia Health Cancer Center
🇺🇸Duluth, Minnesota, United States
Hennepin County Medical Center
🇺🇸Minneapolis, Minnesota, United States
Central Care Cancer Center - Bolivar
🇺🇸Bolivar, Missouri, United States
CoxHealth South Hospital
🇺🇸Springfield, Missouri, United States
FirstHealth of the Carolinas-Moore Regional Hospital
🇺🇸Pinehurst, North Carolina, United States
Wake Forest NCORP Research Base
🇺🇸Winston-Salem, North Carolina, United States
Essentia Health Cancer Center-South University Clinic
🇺🇸Fargo, North Dakota, United States
Geisinger Medical Center
🇺🇸Danville, Pennsylvania, United States
Prisma Health Cancer Institute - Butternut
🇺🇸Greenville, South Carolina, United States
Prisma Health Cancer Institute - Faris
🇺🇸Greenville, South Carolina, United States
ThedaCare Regional Cancer Center
🇺🇸Appleton, Wisconsin, United States
Aurora Cancer Care-Grafton
🇺🇸Grafton, Wisconsin, United States
Aurora Cancer Care-Kenosha South
🇺🇸Kenosha, Wisconsin, United States
Aurora Saint Luke's Medical Center
🇺🇸Milwaukee, Wisconsin, United States
Puerto Rico Hematology Oncology Group
🇵🇷Bayamon, Puerto Rico
Centro Comprensivo de Cancer de UPR
🇵🇷San Juan, Puerto Rico
San Juan City Hospital
🇵🇷San Juan, Puerto Rico